Addiction Medicine & Recovery
A Neuro-Biological Approach
Treating the Brain’s Reward Circuitry
At our practice, we view addiction not as a moral failing, but as a complex, chronic brain disorder characterized by the dysregulation of the neuro-biological alarm and reward systems. When pathways governing dopamine, glutamate, and stress hormones become hijacked by substance use, "willpower" alone is rarely enough for sustainable healing.
Dual-Board Certified Expertise
As a psychiatrist Double Board-Certified in General Psychiatry and Addiction Medicine, I provide a level of specialized care that bridges the gap between traditional recovery models and advanced neuroscience. My approach is rooted in my clinical research into the genetic and epigenetic drivers of addiction, allowing us to repair neural pathways and restore the biological balance necessary for long-term sobriety.
Precision Recovery Protocols
We utilize a medical model for recovery that integrates metabolic health, genomic medicine, advanced psychopharmacology and psychotherapy:
Neuro-Metabolic Repair: Chronic substance use accelerates biological aging and disrupts cellular energy. We use biomarker testing to identify and repair the metabolic damage caused by long-term exposure.
Pharmacogenetic Guidance: We analyze your genetic profile to determine the most effective medications for craving management and relapse prevention, reducing the "trial and error" of traditional prescribing.
GLP-1 & Metabolic Hormone Insight: Based on our published research, we explore how metabolic signaling (such as GLP-1 pathways) can be leveraged to quiet the brain’s "hunger" for substances.
Co-Occurring Disorder Mastery: We simultaneously treat the underlying depression, anxiety, or ADHD that often fuels the cycle of use, ensuring that the "root cause" is addressed alongside the addiction.
The Experience: What to Expect
Our approach to recovery is discreet, data-driven, and focused on long-term neurological restoration.
Neuro-Diagnostic Assessment: A comprehensive 60-90-minute evaluation exploring the history of use, co-occurring conditions (like Depression, ADHD or Anxiety), and the specific triggers of your reward system.
Biological Restoration Mapping: We use advanced labs and genomic testing to identify the physiological "damage" caused by dependency and the genetic keys to your recovery.
The Freedom Blueprint: You receive a custom plan integrating precision medication, metabolic repair, and therapeutic strategies designed to restore your brain’s natural dopamine balance.
Sustained Resilience: Recovery is a dynamic process. We provide ongoing calibration of your treatment to ensure your brain remains resilient against stress, preventing relapse before it starts.
Clinical Research & Selected Publications
Treatment approaches for alcohol use disorder with metabolic dysfunction. Pharmacology & Therapeutics, 2026 >The Insight: This research highlights the critical link between the body's metabolic state and the brain's ability to recover. We treat the whole system—liver health, insulin sensitivity, and brain function—to ensure a robust recovery.
Genetically modeled GLP1R and GIPR agonism reduce binge drinking and alcohol-associated phenotypes: a multi-ancestry drug-target Mendelian randomization study. Molecular Psychiatry, 2025 > The Insight: This study explores how metabolic hormones can be targeted to reduce addictive behaviors. It informs our use of cutting-edge treatments that target the molecular hunger of the reward system.
A multi-omics Mendelian randomization study identifies new therapeutic targets for alcohol use disorder and problem drinking. Nature Human Behavior, 2025 > The Insight: By integrating "multi-omics" data—looking across genes, proteins, and metabolites—this research uses advanced statistical modeling to identify the actual causal drivers of addiction. This allows us to move beyond standard medications and target the specific biological pathways that trigger problem drinking, opening the door for truly personalized, precision addiction medicine.
Targeting Unmet Clinical Needs in the Treatment of Alcohol Use Disorder. Frontiers in Psychiatry, 2022 > The Insight: This work identifies the critical gaps in current addiction treatment—specifically why standard therapies often fail for certain patients. In our practice, we use these insights to address "unmet needs" by integrating metabolic and genomic data, ensuring that patients who have struggled with traditional recovery programs finally have a scientifically tailored path forward.